Researcher from Tsurumi University Discusses Findings in Bone Resorption (Potential for Drug Repositioning of Midazolam as an Inhibitor of Inflammatory Bone Resorption).

A recent report discusses research on bone resorption and the potential for drug repositioning of midazolam as an inhibitor of inflammatory bone resorption. The study conducted experiments using a mouse macrophage-like cell line and evaluated the effects of midazolam on osteoclast differentiation and bone resorption activity. In animal studies, the administration of midazolam showed a decreasing trend in bone resorption. The researchers propose that midazolam could potentially be used for treating inflammatory bone resorption, such as in periodontal disease. [Extracted from the article]